Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE) (PERUSE)
Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE): A Pilot Study
This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.
研究概览
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Nicola F Tavella, MPH
- 电话号码:(212) 241-3888
- 邮箱:nicola.tavella@mssm.edu
研究联系人备份
- 姓名:Kavya Shivashankar, MD
- 电话号码:(212) 241-5681
- 邮箱:kavya.shivashankar@mssm.edu
学习地点
-
-
New York
-
New York、New York、美国、10029
- 招聘中
- Icahn School of Medicine at Mount Sinai
-
接触:
- Nicola F Tavella, MPH
- 电话号码:2122413888
- 邮箱:nicola.tavella@mssm.edu
-
首席研究员:
- Angela Bianco
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients
描述
Inclusion Criteria:
- singleton pregnancy
- no prior diagnosis of diabetes (gestational included)
- scheduled term cesarean delivery in Mount Sinai Health System
- aged 18-50 years
Exclusion Criteria:
- preexisting diabetes mellitus
- diagnosis of gestational diabetes mellitus (GDM) in the current pregnancy, based on standard prenatal screening
- known endocrine disorder affecting glucose metabolism (such as Cushing syndrome, poorly controlled thyroid disorder, etc.)
- use of antenatal steroids within the two weeks prior to delivery
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
scheduled term c-section
Patients scheduled for term cesarean deliveries and who are screened eligible and consented will be administered a continuous glucose monitor prior to their c-section, and they will wear the device through their stay in the hospital. |
Continuous glucose monitor during perioperative Cesarean delivery |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
interstitial glucose from CGM device
大体时间:from pre-operative appointment through end of postpartum hospital stay, up to ten days
|
glucose of interstitial fluid as measured by CGM device on participant's arm |
from pre-operative appointment through end of postpartum hospital stay, up to ten days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of surgical site infection
大体时间:Post-op through end of postpartum hospital say, up to ten days.
|
Diagnosis of surgical site infection as a measure of post-operative complications |
Post-op through end of postpartum hospital say, up to ten days.
|
合作者和调查者
调查人员
- 首席研究员:Angela Bianco, MD、Faculty
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- STUDY-26-00229
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
All of the individual participant data collected during the trial, after deidentification.
IPD 共享时间框架
Immediately following publication. No end date.
IPD 共享访问标准
Researchers who provide a methodologically sound proposal. To achieve aims in the approved proposal. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in the University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found at (Link tbd).
IPD 共享支持信息类型
- 研究方案
- 国际碳纤维联合会
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.